Učitavanje...

HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B

During the natural history of chronic hepatitis B virus (HBV) infection, the loss of serum hepatitis B e antigen (HBeAg) and the development of anti-HBe antibodies (HBeAg seroconversion) mark a transition from the immune-active phase of disease to the inactive carrier state. This review examines the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Liaw, Yun-Fan
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2748370/
https://ncbi.nlm.nih.gov/pubmed/19669245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-009-9140-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!